Literature DB >> 28669872

Minimally Invasive Transforaminal Lumbar Interbody Fusion: A Comparison Study Based on End Plate Subsidence and Cystic Change in Individuals Older and Younger than 65 Years.

Guang-Xun Lin1, Javier Quillo-Olvera1, Hyun-Jin Jo1, Hyeong-Jin Lee1, Claudia Angelica Covarrubias-Rosas1, Chengzhen Jin1, Jin-Sung Kim2.   

Abstract

OBJECTIVE: To compare the outcomes between patients older and younger than 65 years who underwent single-level minimally invasive transforaminal interbody fusion (MI-TLIF) surgery.
METHODS: This study is a retrospective analysis of 76 patients who underwent MI-TLIF between April 2012 and June 2016. Group A consisted of 35 patients (<65 years) and group B consisted of 41 patients (≥65 years). Intraoperative data were recorded. The evaluation of clinical outcomes was based on the visual analog scale for back and leg pain and the Oswestry Disability Index. Radiologic outcomes including cage subsidence, end plate cyst formation, and fusion rate were assessed.
RESULTS: The mean age of the study subjects was 65.3 years, and the mean duration of follow-up was 18.98 months. Group B had a higher rate of comorbidities compared with group A (90.24% vs. 57.14%, respectively; P < 0.05). There was no statistically significant difference in the rate of complications between the groups (group A, 14.29%; group B, 17.07%). Clinical outcomes significantly improved in both groups postoperatively (P < 0.05). Although bony fusion in group A was slightly higher than that in group B, the fusion rate was not statistically different according to age. There were no statistically significant differences in the rates of cage subsidence or positive cyst sign between the groups.
CONCLUSIONS: MI-TLIF presented similar safeness and acceptable outcomes and complication rate in both groups. Cyst formation may be aggravated by cage subsidence, because cage subsidence was a useful potential predictor of cyst formation.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cage subsidence; Elderly; End plate cyst; Minimally invasive; Spine surgery; Transforaminal interbody fusion

Mesh:

Substances:

Year:  2017        PMID: 28669872     DOI: 10.1016/j.wneu.2017.06.136

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  6 in total

1.  Minimally invasive transforaminal lumbar interbody fusion with expandable articulating interbody spacers significantly improves radiographic outcomes compared to static interbody spacers.

Authors:  Anthony J Russo; Steven A Schopler; Katelyn J Stetzner; Torrey Shirk
Journal:  J Spine Surg       Date:  2021-09

2.  Outcomes of oblique lateral interbody fusion for degenerative lumbar disease in patients under or over 65 years of age.

Authors:  Chengzhen Jin; Milin S Jaiswal; Sin-Soo Jeun; Kyeong-Sik Ryu; Jung-Woo Hur; Jin-Sung Kim
Journal:  J Orthop Surg Res       Date:  2018-02-20       Impact factor: 2.359

3.  Defining the MIS-TLIF: A Systematic Review of Techniques and Technologies Used by Surgeons Worldwide.

Authors:  Sara Lener; Christoph Wipplinger; R Nick Hernandez; Ibrahim Hussain; Sertac Kirnaz; Rodrigo Navarro-Ramirez; Franziska Anna Schmidt; Eliana Kim; Roger Härtl
Journal:  Global Spine J       Date:  2020-05-28

4.  Time Course Observation of Outcomes between Minimally Invasive Transforaminal Lumbar Interbody Fusion and Posterior Lumbar Interbody Fusion.

Authors:  Guang-Xun Lin; Chun-Kun Park; Jung-Woo Hur; Jin-Sung Kim
Journal:  Neurol Med Chir (Tokyo)       Date:  2019-05-09       Impact factor: 1.742

5.  Oblique Lumbar Interbody Fusion with Stand-Alone Cages for the Treatment of Degenerative Lumbar Spondylolisthesis: A Retrospective Study with 1-Year Follow-Up.

Authors:  Yachong Huo; Dalong Yang; Lei Ma; Haidong Wang; Wenyuan Ding; Sidong Yang
Journal:  Pain Res Manag       Date:  2020-01-11       Impact factor: 3.037

6.  A pilot study of endoscope-assisted MITLIF with fluoroscopy-guided technique: intraoperative objective and subjective evaluation of disc space preparation.

Authors:  Guang-Xun Lin; Chien-Min Chen; Gang Rui; Jin-Sung Kim
Journal:  BMC Surg       Date:  2022-03-23       Impact factor: 2.102

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.